Department of Biological Sciences, Wayne State University, Detroit, MI 48202, USA.
Cells. 2021 Dec 4;10(12):3416. doi: 10.3390/cells10123416.
Organisms with highly differentiated sex chromosomes face an imbalance in X-linked gene dosage. Male solve this problem by increasing expression from virtually every gene on their single X chromosome, a process known as dosage compensation. This involves a ribonucleoprotein complex that is recruited to active, X-linked genes to remodel chromatin and increase expression. Interestingly, the male X chromosome is also enriched for several proteins associated with heterochromatin. Furthermore, the polytenized male X is selectively disrupted by the loss of factors involved in repression, silencing, heterochromatin formation or chromatin remodeling. Mutations in many of these factors preferentially reduce male survival or enhance the lethality of mutations that prevent normal recognition of the X chromosome. The involvement of primarily repressive factors in a process that elevates expression has long been puzzling. Interestingly, recent work suggests that the siRNA pathway, often associated with heterochromatin formation and repression, also helps the dosage compensation machinery identify the X chromosome. In light of this finding, we revisit the evidence that links nuclear organization and heterochromatin to regulation of the male X chromosome.
具有高度分化性染色体的生物面临着 X 连锁基因剂量失衡的问题。雄性通过增加其单个 X 染色体上几乎所有基因的表达来解决这个问题,这个过程被称为剂量补偿。这涉及到一种核糖核蛋白复合物,它被招募到活性的 X 连锁基因上,重塑染色质并增加表达。有趣的是,雄性 X 染色体还富含几种与异染色质相关的蛋白质。此外,多倍化的雄性 X 染色体选择性地被涉及抑制、沉默、异染色质形成或染色质重塑的因子的缺失所破坏。这些因子中的许多突变优先降低雄性的存活率,或增强阻止正常识别 X 染色体的突变的致死性。在一个提高表达的过程中主要涉及抑制因子,这一直是令人困惑的。有趣的是,最近的研究工作表明,siRNA 途径,通常与异染色质形成和抑制有关,也有助于剂量补偿机制识别 X 染色体。有鉴于此,我们重新审视了将核组织和异染色质与雄性 X 染色体调控联系起来的证据。